We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
285 hedge funds and large institutions have $2.9B invested in Corcept Therapeutics in 2024 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 103 increasing their positions, 114 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
31% more call options, than puts
Call options by funds: $47.4M | Put options by funds: $36.1M
23% more capital invested
Capital invested by funds: $2.36B → $2.9B (+$536M)
9% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 34
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
1% less funds holding
Funds holding: 287 → 285 (-2)
10% less repeat investments, than reductions
Existing positions increased: 103 | Existing positions reduced: 114
4.9% less ownership
Funds ownership: 90.62% → 85.72% (-4.9%)
Holders
285
Holders Change
-2
Holders Change %
-0.7%
% of All Funds
4.12%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
37
Increased
103
Reduced
114
Closed
34
Calls
$47.4M
Puts
$36.1M
Net Calls
+$11.3M
Net Calls Change
+$28.8M
Top Buyers
Top Sellers
| 1 |
Man Group
London,
United Kingdom
|
-$18.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$13.7M |
| 3 |
Two Sigma Investments
New York
|
-$11.6M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$8.85M |
| 5 |
First Trust Advisors
Wheaton,
Illinois
|
-$8.69M |
